Stocks Carry Steep Losses Into A Second Straight Day After Bernanke Announces End of QE

Michael Teague |

The frenzied reaction to Fed Chairman Ben Bernanke’s announcement on Wednesday that quantitative easing would conclude by mid-2014 carried over into Thursday’s trading activity as the global sell-off gained frightening momentum.

Indices suffered major losses across the board, nearly doubling the previous day’s performance as investors attempted to digest the confirmation they had been asking for regarding when and how the Federal Reserve would remove the training wheels from the U.S. economy.

The S&P 500 was off 2.50 percent to close at 1,588.19, while the Dow dropped 2.34 percent to 14,758.32 and the Nasdaq was down 2.28 percent to end the day at 3,364.64 points, while the yield on 10-year Treasury bonds neared 2.50 percent for the first time in two years.

Nor was the blow softened by a corresponding uptick in commodities or “safe havens”, with gold down 7 percent, silver down 9 percent, and smaller but significant losses for oil, natural gas, corn, and rice. Furthermore, the news was exacerbated by economic data coming out of China that indicated a second consecutive month of slowing growth.

It is hard to imagine that markets seriously believed that the Fed’s fiscal policy would remain a permanent feature of the economy. However, the sell-off took on a global character overnight that made what at first appeared to be an overreaction or de facto correction look dangerously like a full-on bear market, at least from the perspective of real-estate and utilities that are now down more than 10 percent from their 52-week highs.

The Dow’s biggest losers were Walt Disney Co. (DIS), Intel (INTC), and Microsoft (MSFT), while the S&P 500 bore the brunt of petrified real-estate stocks. The Index’s top three losers for the day were residential construction companies PulteGroup Inc. (PHM), DR Horton Inc. (DHI), and Lennar Corp. (LEN), all down more than 7.50 percent, with a number of REITs in tow such as Boston Properties Inc. (BXP) and American Tower Corporation (AMT).

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Spotlight

BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.

Events

EQUITIES Emerging Growth and Innovation Forum

EQUITIES Inaugural Emerging Growth and Innovation Forum at Disruptive firm MRY New York City's Flatiron District. The forum is on February 24th from 12:00 pm to 6:00 pm with a…

Learn more

Research

MagneGas Corporation (MNGA)

MagneGas Corporation is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification and sterilization of liquid and liquid waste. ($49 USD)

Learn more

Private Markets

SU Labs Accelerator Seed Fund

We're a fiercely passionate community of entrepreneurs leveraging rapidly accelerating technologies to create a brighter future. Join us in fostering innovation, driving impact and funding the future.

FAB Financial Inc.

Banking is broken. Years ago people who needed business advice would turn to their local bank manager for help. The banker was thought of as a trusted member of the…